Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classifica tra le azioni #20515
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Prezzo delle azioni
$20.38
Capitalizzazione di mercato
$129.09M
Variazione (1 giorno)
-0.82%
Variazione (1 anno)
80.91%
Paese
PL
Scambia Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Storico del prezzo dell'azione per Captor Therapeutics Spolka Akcyjna (CTX)
Prezzo di chiusura più alto: $20.25 il 2026-08-01

Prezzo di chiusura più basso: $45.81 il 2021-04-01
Storico del prezzo dell'azione di Captor Therapeutics Spolka Akcyjna dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -1.92%
2025 68.95%
2024 -54.45%
2023 -32.61%
2022 -15.45%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$766.03 8.39%
CH